亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Cost-Effectiveness of Second-Line Endocrine Therapies in Postmenopausal Women with Hormone Receptor-positive and Human Epidermal Growth Factor Receptor 2-negative Metastatic Breast Cancer in Japan.

乳腺癌 癌症 激素受体 表皮生长因子受体 人表皮生长因子受体2 芳香化酶抑制剂 阿那曲唑
作者
Verin Lertjanyakun,Nathorn Chaiyakunapruk,Susumu Kunisawa,Yuichi Imanaka
出处
期刊:PharmacoEconomics [Adis, Springer Healthcare]
卷期号:36 (9): 1113-1124 被引量:2
标识
DOI:10.1007/s40273-018-0660-3
摘要

Exemestane (EXE), exemestane + everolimus (EXE + EVE), toremifene (TOR), and fulvestrant (FUL) are second-line endocrine therapies for postmenopausal hormone receptor–positive (HR +)/human epidermal growth factor receptor 2–negative (HER2 −) metastatic breast cancer (mBC) in Japan. Although the efficacy of these therapies has been shown in recent studies, cost-effectiveness has not yet been determined in Japan. This study aimed to examine the cost-effectiveness of second-line endocrine therapies for the treatment of postmenopausal women with HR + and HER2 − mBC. A Markov model was developed to analyze the cost-effectiveness of the therapies over a 15-year time horizon from a public healthcare payer’s perspective. The efficacy and utility parameters were determined via a systematic search of the literature. Direct medical care costs were used. A discount rate of 2% was applied for costs and outcomes. Subgroup analysis was performed for non-visceral metastasis. A series of sensitivity analyses, including probabilistic sensitivity analysis (PSA) and threshold analysis were performed. Base-case analyses estimated incremental cost-effectiveness ratios (ICERs) of 3 million and 6 million Japanese yen (JPY)/quality-adjusted life year (QALY) gained for TOR and FUL 500 mg relative to EXE, respectively. FUL 250 mg and EXE + EVE were dominated. The overall survival (OS) highly influenced the ICER. With a willingness-to-pay (WTP) threshold of 5 million JPY/QALY, the probability of TOR being cost-effective was the highest. Subgroup analysis in non-visceral metastasis revealed 0.4 and 10% reduction in ICER from the base-case results of FUL5 500 mg versus EXE and TOR versus EXE, respectively, while threshold analysis indicated EVE and FUL prices should be reduced 73 and 30%, respectively. As a second-line therapy for postmenopausal women with HR +/HER2 − mBC, TOR may be cost-effective relative to other alternatives and seems to be the most favorable choice, based on a WTP threshold of 5 million JPY/QALY. FUL 250 mg is expected to be as costly and effective as EXE. The cost-effectiveness of EXE + EVE and FUL 500 mg could be improved by a large price reduction. However, the results are highly sensitive to the hazard ratio of OS. Policy makers should carefully interpret and utilize these findings.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
星辰大海的应助被找找采纳,获得10
1秒前
李健的应助被椰子云采纳,获得10
2秒前
Uu发布了新的文献求助10
4秒前
可爱的函函的应助被Zhu采纳,获得10
6秒前
啊九lili完成签到,获得积分20
7秒前
9秒前
荀冰姬发布了新的文献求助10
10秒前
13秒前
13秒前
Saki发布了新的文献求助10
13秒前
Lucas的应助被王老裂采纳,获得10
18秒前
留胡子的鸿涛完成签到,获得积分10
19秒前
木子媚媚发布了新的文献求助20
19秒前
Zhu发布了新的文献求助10
20秒前
高兴中心完成签到,获得积分10
24秒前
FashionBoy的应助被荀冰姬采纳,获得10
25秒前
Zhu完成签到,获得积分10
27秒前
28秒前
28秒前
Tengjingshu完成签到 ,获得积分10
33秒前
35秒前
35秒前
xylxyl发布了新的文献求助10
36秒前
Wjx完成签到,获得积分10
42秒前
搜集达人的应助被Uu采纳,获得10
42秒前
荀冰姬完成签到,获得积分10
45秒前
li完成签到,获得积分10
48秒前
务实老姆完成签到,获得积分10
57秒前
赘婿的应助被木子媚媚采纳,获得10
59秒前
1分钟前
开放的子默完成签到,获得积分10
1分钟前
1分钟前
1分钟前
嘻嘻哈哈完成签到,获得积分10
1分钟前
1分钟前
Maestro_S的应助被闪闪婴采纳,获得10
1分钟前
令狐惜海的应助被闪闪婴采纳,获得10
1分钟前
碧蓝皮卡丘完成签到,获得积分10
1分钟前
Lee完成签到 ,获得积分10
1分钟前
Linson完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158601
求助须知:如何正确求助?哪些是违规求助? 9554379
关于积分的说明 21719104
捐赠科研通 7748129
什么是DOI,文献DOI怎么找? 3427052
关于科研通互助平台的介绍 2551912
邀请新用户注册赠送积分活动 2471285